You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in Psoriasis

The Path Toward Clear Skin

The treatment of psoriasis has advanced substantially due to therapies that target key immune pathways involved in disease pathophysiology. As the therapeutic options for psoriasis expand, members of the healthcare team need a better understanding of how to use various medications and where they can be most optimally used. Patients and clinicians have set their sights on clear skin and minimal disease impact on quality of life as treatment goals. Partnership and shared decision making are increasingly important to achieve these goals in the management of psoriasis.

Supported by an independent educational grant from

Ortho Dermatologics, a division of Bausch Health

CME Activities

Polling Question

Related Resources

Steering Committee

Mark G. Lebwohl, MD

Steering Committee Co-Chair

Chairman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Alan Menter, MD

Steering Committee Co-Chair

Chairman of Dermatology
Baylor University Medical Center Dallas
Dallas, Texas

Lakshi Aldrege, MSN, ANP-BC

Nurse Practitioner, Dermatology
VA Portland Healthcare System
Portland, Oregon

April W. Armstrong, MD, MPH

Professor of Dermatology
Associate Dean for Clinical Research
Director of Clinical Research Support
Southern California Clinical and Translational Science Institute (SC CTSI)
Vice Chair and Director, Clinical Trials and Outcomes Research
Director, Psoriasis Program
Department of Dermatology
Keck School of Medicine at USC
University of Southern California
Los Angeles, California

Boni Elewski, MD

Department of Dermatology
University of Alabama at Birmingham

Abby S. Van Voorhees, MD

Program Director
Eastern Virginia Medical School
Norfolk, Virginia